In our latest episode, an expert explains why pharma teams must include allied health professionals in their key engagements.
Our expert discusses why pharma teams should use social monitoring to avoid missing out on critical information.
Listen to a short podcast to understand how embracing, accepting, and managing change can make or break a new tech implementation.
Within3 experts share insight on how medical affairs teams can benefit from the data they collect.
Time with your KOLs and medical affairs program stakeholders is precious. How can you make the most of it?
Learn why medical affairs organizations are using data and network analytics to identify KOLs and DOLs to drive insights generation.